Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis (Q28294866)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q50793922)
(Q30004422)
(Q2177653)
(P304) 3479-88
(P407) (Q1860)
(P433) 24
(P478) 25
(P577) Thursday, June 8, 2006
(P921) (Q128581)
(P1433) (Q1568657)
(P1476) "Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis" (language: en)
(P2093) D Niederacher
H An
F Wiesmann
B Betz
O Galm
O Camara
M Dürst
G Kristiansen
C Huszka
E Dahl
(P2860) (Q22009909)
(Q28286884)
(Q24801811)
(Q29547527)
(Q28243955)
(Q30885681)
(Q28297342)
(Q29547437)
(Q24311356)
(Q31978191)
(Q28260824)
(Q24310637)
(Q29617274)
(Q24631957)
(Q24656704)
(Q28268844)
(Q35679187)
(Q28251350)
(Q35004950)
(Q59313166)
(Q73157863)
(Q21195245)
(Q73085107)
(Q28245608)
(Q34126908)
(Q28251800)
(Q40506716)
(Q27860717)
(Q41400379)
(Q74623191)
(Q28191099)
(Q22011203)
(Q24302305)
(Q44488217)